PREDICTORS OF PRIMARY PATENCY FAILURE IN WALLSTENT(R) SELF-EXPANDING ENDOVASCULAR PROSTHESES FOR ILIOFEMORAL OCCLUSIVE DISEASE

Citation
S. Damaraju et al., PREDICTORS OF PRIMARY PATENCY FAILURE IN WALLSTENT(R) SELF-EXPANDING ENDOVASCULAR PROSTHESES FOR ILIOFEMORAL OCCLUSIVE DISEASE, Texas Heart Institute journal, 24(3), 1997, pp. 173-178
Citations number
8
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
07302347
Volume
24
Issue
3
Year of publication
1997
Pages
173 - 178
Database
ISI
SICI code
0730-2347(1997)24:3<173:POPPFI>2.0.ZU;2-L
Abstract
We studied the factors that affected the primary patency and the clini cal and procedural success of WALLSTENTS(R) (stents) that were used at our institution from 1 March 1994 To 30 October 1995 for the treatmen t of iliac and femoral artery occlusive disease. This prospective stud y comprised 63 patients with 82 lesions. Follow-up was performed for a mean duration of 18.7 months. Pre-and post-procedural duplex ultrason ography, together with estimation of ankle-brachial index scores, was performed on all patients, and additional studies were performed at cl inical follow-up if indicated. The technical success rate was 100%. An kle-brachial index scores improved considerably from 0.52 +/- 0.21 bef ore the procedure to 0.73 +/- 0.27 after the procedure. The significan t predictors by univariate analysis of primary patency failure were: F ontaine class ill or IV (P=0.044); femoral location (P=0.004); lesion length >100 mm (P=0.010); poor or moderate outflow (P=0.026); and numb er of stents greater than or equal to 3 (P=0.012). Cox regression anal ysis showed that greater than or equal to 3 stents (risk ratio=5.61), poor or moderate outflow (risk ratio=6.05), and femoral location (risk ratio=5.61 were the significant predictors of primary patency failure . Femoral lesions required more stents than did iliac lesions (2.2 +/- 10.8 vs 1.3 +/- 0.5). Primary patency rates for iliac and femoral ste nts were 86% and 49%, respectively at 12 months, and 82% and 41% at 24 months.